Cargando…
Sodium Butyrate Inhibits Neovascularization Partially via TNXIP/VEGFR2 Pathway
Control of neovascularization with small molecules is a promising tactics. Here, we tested the roles of sodium butyrate (NaBu) on the neovascularization and primary explained its underlining molecular links. We used models including cell and ex vivo culture of choroid and mouse, as well as the bioch...
Autores principales: | Xiao, Xiaoqiang, Chen, Min, Xu, Yanxuan, Huang, Shaofen, Liang, Jiajian, Cao, Yingjie, Chen, Haoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700023/ https://www.ncbi.nlm.nih.gov/pubmed/33274003 http://dx.doi.org/10.1155/2020/6415671 |
Ejemplares similares
-
Sodium butyrate‐activated TRAF6‐TXNIP pathway affects A549 cells proliferation and migration
por: Xiao, Xiaoqiang, et al.
Publicado: (2019) -
Reduction of Laser-Induced Choroidal Neovascularization in Mice With Erythropoietin RNA Interference
por: Lv, Wenjuan, et al.
Publicado: (2022) -
Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation
por: Kim, Jeong Hun, et al.
Publicado: (2009) -
Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway
por: Wang, Xukai, et al.
Publicado: (2015) -
Sodium Butyrate Attenuates Diabetic Kidney Disease Partially via Histone Butyrylation Modification
por: Zhou, Tingting, et al.
Publicado: (2022)